Find comprehensive information on lung cancer diagnosis including clinical documentation, medical coding (ICD-10-CM C34), symptoms, staging (TNM), treatment options, and healthcare resources. Learn about lung cancer types like non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), pulmonary nodules, and the role of radiology and pathology in diagnosis. Explore resources for patients, physicians, and coding professionals seeking accurate and up-to-date information on lung cancer.
Also known as
Malignant neoplasm of bronchus and lung
Covers cancers originating in the bronchi and lungs.
Secondary malignant neoplasm of lung
Identifies lung cancer that has spread from another primary site.
Malignant neoplasm without specification of site
Used when the specific location of the lung cancer is unknown.
Personal history of malignant neoplasm of lung
Indicates a past diagnosis of lung cancer, currently in remission or cured.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the lung cancer malignant?
Yes
Is histology confirmed?
No
In situ?
When to use each related code
Description |
---|
Lung Cancer |
Mesothelioma |
Secondary Lung Cancer |
Missing or incorrect laterality (right, left, bilateral) for lung cancer diagnosis (C34.x) impacts staging, treatment, and reimbursement.
Unspecified histology for lung cancer lacks detail for accurate coding (C34.x subtypes), affecting quality metrics and research.
Incomplete staging documentation (TNM) for lung cancer (C34.x) leads to inaccurate code assignment, impacting treatment planning and payment.
Patient presents with complaints consistent with possible lung cancer, including persistent cough, hemoptysis, dyspnea, and unintentional weight loss. Onset of symptoms reported as [timeframe]. Patient history includes [smoking history, occupational exposures, family history of lung cancer, relevant comorbidities such as COPD or emphysema]. Physical examination reveals [relevant findings such as diminished breath sounds, wheezing, lymphadenopathy]. Preliminary differential diagnosis includes lung cancer, pneumonia, bronchitis, tuberculosis. Ordered tests include chest x-ray, CT scan of the chest, and complete blood count. Imaging studies suggest [description of findings, e.g., presence of a nodule, mass, or effusion]. Pulmonary function tests were conducted to assess lung capacity and function. Further evaluation with bronchoscopy and biopsy is recommended to obtain a tissue diagnosis and determine histological subtype, such as non-small cell lung cancer (NSCLC) including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma, or small cell lung cancer (SCLC). Staging workup will be performed to assess the extent of disease using TNM staging. Treatment options will be discussed with the patient following confirmation of diagnosis and staging, which may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, or palliative care. Referral to oncology and pulmonology is made. Patient education provided regarding lung cancer symptoms, diagnosis, treatment options, and prognosis. Follow-up appointment scheduled for [date].